Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer. [electronic resource]
Producer: 20200407Description: 54-58 p. digitalISSN:- 1872-8332
- Acrylamides -- therapeutic use
- Adult
- Aged
- Aniline Compounds -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Neoplasm Staging
- Protein Kinase Inhibitors -- therapeutic use
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.